JESSICA ENOS: Open Payments
NPI 1376273904 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 12 payments from 3 companies in 2025. Trend: 2023 $1,884 · 2024 $1,733 · 2025 $364
Food & beverage: $264Education: $100
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $174 |
| Teva Pharmaceuticals USA, Inc. | 8 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: INGREZZA, AUSTEDO XR, CAPLYTA.
Industry payments across FL — which companies pay providers there.
